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Summary 
To  ensure  self tolerance,  immature  thymocytes  with  high  binding  affinity  for  self peptides 
linked to major histocompatibility complex (MHC)  molecules are eliminated in situ via apop- 
tosis (negative selection). The roles of two costimulatory molecules, B7-1  and intercellular  ad- 
hesion molecule-1  (ICAM-1),  in negative selection was examined by studying apoptosis of T 
cell  receptor  transgenic  CD4+8 +  thymocytes  cultured  with  specific  peptides  presented  by 
MHC  class  I-transfected Drosophila  cells. When coexpressed on these cells, B7-1  and ICAM-1 
act synergistically  and  cause  strong  class  I-restricted  negative  selection  of thymocytes.  When 
expressed separately,  however,  B7-1  and  ICAM-1  display opposite functions:  negative  selec- 
tion is augmented by B7-1, but is inhibited by ICAM-1. It is notable that B7-1  is expressed se- 
lectively  in  the  thymic  medulla,  whereas  ICAM-1  is expressed  throughout  the  thymus.  Be- 
cause of this distribution,  the differing functions of B7-1  and ICAM-1  may dictate the sites of 
positive and negative selection. Thus, in the cortex, the presence of ICAM-1, but not B7-1, on 
the  cortical  epithelium  may preclude  or reduce  negative selection and thereby promote posi- 
tive selection.  Conversely, the combined expression of B7-1  and ICAM-1  may define the me- 
dulla as the principal site of negative selection. 
S 
timulation of mature T  cells is controlled by bone mar- 
row-derived APC and requires TCR  contact with pep- 
tide/MHC  complexes plus  interaction  with  costimulatory 
molecules  such as B7  (B7-1  or B7-2)  and intercellular  ad- 
hesion molecule-/  (ICAM-11;  1-3).  This  requirement  for 
joint  contact with peptide/MHC  complexes and costimu- 
latory molecules also applies to negative selection (deletion) 
of immature  T  cells in the  thymus  (4-10).  It is uncertain, 
however, which  particular costimulatory molecuies are re- 
quired for negative selection. 
Using  a  TCR  transgenic  mouse  model  and  transfected 
Drosophila  cells as APC, we show here that the importance 
of costimulation for negative selection is variable and is in- 
fluenced  by  the  binding  affinities  involved  in  TCR/pep- 
tide/MHC  interaction.  In  addition,  evidence  is presented 
that two costimulatory molecules,  B7-1  and ICAM-1,  can 
play opposite roles in negative selection. 
Materials  and Methods 
Mice.  2C TCR transgenic  mice were originally  obtained from 
Dr. D. Loh (Nippon Roche Research Center, Kamakura-shi, Ja- 
1Abbreviations used in &is paper: DP, double positive; ICAM-1, intercellu- 
lar adhesion molecule-I; LFA-I, leukocyte function antigen-1. 
pan)  (11),  and were bred, back-crossed to [32 microglobulin -/- 
([52m  -/-) mice, and maintained at The Scripps Research Institute. 
Antibodies.  Antibodies  specific  for  CD8  (3.163.8,  rat  IgM) 
and CD3  (C363.29B,  rat  IgG) were  previously described  (12). 
Rabbit anti-mouse Bcl-XL and Bax were kindly provided by Dr. 
John Reed (La Jolla Cancer Research Foundation,  La Jolla, CA) 
(13,  14). The following mAbs were purchased from PharMingen 
(San Diego, CA); anti-Bcl-2  (3Fll,  hamster IgG), anti-lympho- 
cyte function  antigen-I  (LFA-1)  (M17/4,  rat  IgG), anti-CD43 
($7,  rat IgG), and  anti-ICAM-1  (3E2,  hamster IgG). FITC- or 
Red613-conjugated anti-Thy 1.2 (30H12, rat IgG) and Red613- 
conjugated  anti-CD8  (53-6.7,  rat  IgG)  mAbs  were  purchased 
from  GIBCO  BRL  (Gaithersburg,  MD).  Goat  anti-rat  Ig and 
FITC-conjugated  goat  anti-rabbit  IgG  were  purchased  form 
Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). 
Peptides.  Two  peptides  p2Ca  (sequence:  LSPFPFDL)  and 
QL9  (QLSPFPFDL)  were  used  in  this  study  (15-19).  Peptides 
were synthesized on a synthesizer (model 431  A; Applied Biosys- 
tems, Inc., Foster City, CA), and were purified with C18 reverse- 
phase high performance liquid chromatography. 
Cell Lines and Cell Purification.  Drosophila APC were constructed 
by transfecting  Schneider SC2 cells with cDNA for L  a, 132-micro- 
globulin  ([~2m), B7-1,  and/or  ICAM-1  as  described  elsewhere 
(reference  20  and  Cai,  Z.,  A.  Brunmark,  M.R.  Jackson,  P.A. 
Peterson,  and J.  Sprent,  manuscript  submitted  for publication); 
control cells were  transfected with cDNA for D b and ICAM-1. 
Cell-surface expression was moderate and no higher than on nor- 
real  spleen  cells.  For  purification  of CD4+8 +  (double-positive 
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mice  were  depleted  of contaminating  TCR_  high single-positive 
cells by  treatment  with  anti-CD3  mAb  and  guinea  pig  C  for 
45 min  at  37~  followed  by  positive  panning  on  anti-CD8 
n~Ab-coated plates  (21);  the resulting  TCR  l~  DP cells rapidly 
upregulate TCR expression  when cultured in vitro and behave 
indistinguishably  from  unseparated  [~2m  -/  2C  thymocytes. 
Since contamination with TCR.  high CD4-8 + cells in 132m  -/- 2C 
thynmcytes is minimal,  unseparated  [32m  -/  2C thymocytes were 
used in some experiments.  The results obtained with these  cells 
were essentially the same as for purified DP cells. 
Culture Conditions.  2C DP thymocytes were cultured for 20 h 
at 5 ￿  10  ~/well with 2 ￿  105 transfected Drosophila  cells in 0.2 ml 
of  R.PMI medium supplemented  with 5 X 10 -5 M 2-ME, t-gluta- 
mine,  and  10%  FCS;  peptides  were  added  at  10  IxM.  For the 
studies  involving soluble  anti-LFA-1  and anti-CD43 mAbs,  2C 
DP thymocytes were pretreated  with  10  txg/ml of either anti- 
LFA-1 or anti-CD43 or both mAbs for 30 min, washed,  and then 
cultured with La.ICAM APC plus QL9. For soluble  anti-ICAM 
mAb, La.ICAM or L  a APC were pretreated  with  10  Ixg/ml of 
anti-ICAM-1 mAb for 30 min, washed,  and then added to cul- 
ture with 2C DP thymocytes plus QL9. For the studies involving 
cross-linked  antibodies,  cultures  containing antibody-pretreated 
DP cells or APC were supplemented with 5 txg/ml of goat anti- 
rat Ig; this antibody, which cross-reacts  with hamster Ig, was left 
in the cultures  until TUNEL staining. 
Staining  for Cell Sulface and lntracellular  Molecules.  For cell-sur- 
face staining,  cells were  incubated  with  FITC-conjugated anti- 
CD69  and  Red613-conjugated  anti-Thyl.2  mAbs,  and  fixed 
with 70% ethanol and 1% paraformaldehyde in PBS.  For Bcl-2, 
Bcl-Xt, and Bax staining,  cells were first stained  with Red613- 
conjugated anti-Thy1.2 mAb, fixed with 1% parafomlaldehyde in 
PBS  containing  0.1%  glutaraldehyde,  0.02%  Tween  20,  then 
TUNEL stained.  Thereafter,  the cells were incubated with either 
anti-Bcl-2, rabbit  anti-mouse-Bcl-XL, or rabbit  anti-mouse-Bax 
antibodies,  and  then  stained  with  FITC-conjugated goat  anti- 
hamster Ig. Cells were analyzed on a FACScan  |  (Becton Dickin- 
son  &  Co.,  Mountain  View,  CA),  gating  on  Thyl.2  +  and 
TUNEL- cells. 
TUNEL Assay and DNA Staining.  TUNEL  assay and  DNA 
staining by propidium iodide were described  previously (21, 22). 
Results  and Discussion 
The requirements for inducing negative selection of thy- 
mocytes were investigated with the aid of the MHC  class 
I-restricted  2C  transgenic  line  as  a  source  of thymocytes, 
defined  peptides  as  antigen,  and  MHC  class  I-transfected 
Drosophila cells  as  APC.  Drosophila  cells  have  two  advan- 
tages  for studying APC  function.  First,  as  expected  from 
their  distant  relationship  to mammalian T  cells,  the  native 
cell-surface molecules on Drosophila cells do not display co- 
stimulatory function for mature T  cells  (Cai,  Z., A. Brun- 
mark,  M.R. Jackson,  P.A.  Peterson,  and J.  Sprent,  manu- 
script  submitted  for  publication.  Second,  Drosophila cells 
lack  TAP-l,2  peptide  transporters  (20,  23),  which  means 
that,  after transfection,  the class I molecules on the surface 
of these cells can be loaded with high concentrations of ex- 
ogenous peptides  (20). 
Drosophila cells  were transfected with MHC  class  I  (La), 
B7-1  (B7), or ICAM-1  (ICAM) genes linked to the metal- 
lothionein  promoter  (20)  (Materials  and  Methods).  These 
cells  were then tested for their capacity to present  peptide 
antigens to immature thymocytes taken from 2C TCR trans- 
genic mice (11). The 2C line displays strong reactivity to L d 
molecules  complexed  with  an  8-mer  peptide,  p2Ca,  de- 
rived from a Krebs cycle enzyme (15,  16). This natural pep- 
tide has intermediate  affinity for soluble L a molecules (4  ￿ 
106 M -1) and (when complexed to L d) high affinity for 2C 
TCR molecules (2 ￿  106 M -1 to I  ￿  107 M -1) (17-19). A 
closely related 9-mer peptide,  QL9, has even higher affinity 
for these molecules (2  ￿  108 M -1 for L a and 2  ￿  107 M -t 
for 2C TCR); QL9 is derived from the same self protein as 
p2Ca and,  except for one additional  amino acid,  QL9 has 
the same sequence as p2Ca (16). 
To  study  negative  selection,  purified  CD4+8 +  thymo- 
cytes from 2C mice were incubated in vitro with p2Ca or 
QL9 peptides presented by a panel oftransfected Drosophila 
cells  expressing  L a  alone  (L  a APC),  L d plus  B7-1  (Ld.B7 
APC), L a plus  ICAM-1  (Ld.ICAM APC),  or L  a plus B7-1 
and ICAM-1  (Ld.B7.1CAM APC).  Negative selection was 
measured  by quantitating  T  cell  apoptosis  using  TUNEL 
staining  and  FACS  |  (Becton  Dickinson  &  Co.)  analysis 
(21);  this  method  relies  on  the  fact  that  through  DNA 
strand breaks, apoptotic cells  incorporate exogenous nucle- 
otides  (dUTP)  in the  presence  of terminal  deoxynucleoti- 
dyl transferase  (22).  As  expected,  incubating  CD4+8 +  2C 
thymocytes with QL9 peptide and Ld-transfected Drosophila 
cells  coexpressing both B7 and ICAM causes  strong nega- 
tive  selection  (apoptosis)  relative  to  control  cells  (tram- 
fected Drosophila cells not induced with CuSO4; Fig.  1 a). 
Data  on  negative  selection  and  CD69  expression  in- 
duced  by  the  panel  of Ld-transfected  Drosophila  cells  and 
p2Ca vs QL9 peptides  (10 wM) are shown in Fig.  1 b; the 
data  are  the  mean  of three  separate  experiments,  and  the 
level  of  background  apoptosis  found  with  uninduced 
Drosophila  cells  has  been  subtracted.  The  data  make  four 
points.  First,  with  APC  expressing  L  't  alone,  the  strong 
QL9 peptide induces a low but significant level of negative 
selection  (apoptosis)  associated with upregulation of CD69 
on the surviving (TUNEL-)  cells;  by contrast,  the weaker 
p2Ca peptide induced neither CD69 expression nor nega- 
tive  selection.  Second,  with  La.B7  APC,  the  presence  of 
B7-1  augments negative selection  to QL9 and reveals low 
but significant negative selection to p2Ca; both peptides in- 
duce strong CD69 expression.  Third, La.ICAM APC para- 
doxically induce strong CD69 expression  but fail  to cause 
negative selection, either to QL9 or to p2Ca.  Fourth, with 
Ld.B7.ICAM APC,  negative  selection  to  both  peptides  is 
stronger than with Ld.B7 APC. 
Two aspects of the above data are surprising:  (a)  the ca- 
pacity ofL  a APC to elicit apoptosis to the strong QL9 pep- 
tide;  and  (b)  the  lack  of apoptosis  found  with  La.ICAM 
APC. Further data on these two points are discussed below. 
The low but significant level of apoptosis induced by L d 
APC plus QL9 is associated with weak upregulation of Bcl-2 
(contrasting with strong CD69 expression)  and no change 
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Figure  1.  Negative  selection  of 
immature  2C  thymocytes  by trans- 
fected  Drosophila  cells.  Purified 
CD4+8 + thymocytes  were prepared 
from (iB2m  -/- 2C mice and cultured 
in  vitro  overnight  (16-24  h)  with 
transfected  Drosophila cells  in  the 
presence  of the  peptides  (10  IxM) 
shown  (Materials and  Methods); 
apoptosis was measured  by TUNEL 
staining and FACS|  analysis. (a) An 
example  of  thymocyte  apoptosis 
(TUNEL staining)  induced  by cul- 
turing  2C  thymocytes  with 
Ld.B7.ICAM  Drosophila cells  over- 
night with or without QL9 peptide. 
Drosophila  cells  not  induced  with 
CuSO  4 were used as a negative con- 
trol;  in  other  experiments,  back- 
ground apoptosis ofthymocytes cul- 
tured  overnight  with  uninduced 
Drosophila cells was generally a little 
higher,  i.e.,  20-25%.  (b)  Compari- 
son  of apoptosis and  CD69  expres- 
sion  induced  by  culturing  2C  thy- 
mocytes  with  transfected  Drosophila 
cells with  p2Ca  vs.  QL9  peptides. 
For apoptosis, the data represent the 
mean of three  separate experiments; 
background  apoptosis  observed 
with  uninduced  Drosophila cells has 
been subtracted. CD69 expression is 
shown  for  viable  (TUNEL-)  cells. 
The data at the right summarize  the 
capacity  of  transfected  Drosophila 
APC to induce purified  CD8  + LN 
2C  cells to  mount  proliferative  re- 
sponses in  vitro to  p2Ca  and  QL9 
peptides  in  the  absence  of  added 
cytokines.  (c)  Expression  of Bcl-2, 
BcI-X  L, and Bax on 2C thymocytes 
after culture with the Drosophila APC 
shown plus  QL9 peptide  (10  ~M). 
The  data show  staining  of  viable 
(TUNEL-) cells. For Bcl-2, the pro- 
portion  of stained  cells  relative  to 
background  staining  with  normal 
hamster Ig is shown; for BcI-XL and 
Bax,  control  staining  with  normal 
rabbit  serum  is  shown  in  the  filled 
histograms. 
in  the  expression  of Bcl-X  L or Bax  (Fig.  1  c);  these  three 
members  of the Bcl-2 family are known  to inhibit or aug- 
ment  apoptosis  in  other systems  (24).  QL9-induced  apop- 
tosis with L d APC  is most apparent late in culture  (Fig. 2  a, 
/eft),  and is more easily detectable by TUNEL  staining (Fig. 
2  a, left) than with the less-sensitive propidium iodide tech- 
nique  (which detects  cells with subdiploid DNA)  (Fig. 2  a, 
right).  Apoptosis  elicited by L d APC  is only seen with rela- 
tively high doses ofQL9  peptide,  i.e.,  ~10  nM  (108  M -1) 
(Fig.  2  b),  and  is  undetectable  with  up  to  10  DM  of the 
weaker p2Ca peptide (Fig.  1 b); these findings contrast with 
Ld.BT.ICAM  APC,  where  apoptosis  to  QL9  is  apparent 
with as low as 10 fM  (10 TM M -1)  (Fig. 2  b).  Apoptosis with 
L d APC  is thus  only seen with high  doses  of an  extremely 
high  affinity peptide.  The implication  therefore  is that  the 
requirement  for costimulation  in negative selection can be 
partly  overcome  by  very  strong  signaling  through  the 
TCR.  This  differs  from  mature  T  cells  where  2C  LN 
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Figure 2.  Kinetics  and dose of QL9 peptide required for negative se- 
lection of 2C CD4+8 + thymocytes with Drosophila APC. (a) Kinetics of 
apoptosis induced by 10 mM QL9 peptide as measured by TUNEL stain- 
ing (leO) and staining for subdiploid DNA with propidium iodide (fight). 
(b) Concentration of QL9 peptide required to induce apoptosis as mea- 
sured by TUNEL staining at 20 h. 
CD8 + cells cannot be activated by L d APC plus QL9; data 
on  the  capacity of the panel of transfected Dwsophila  cells 
to  stimulate  mature  2C  T  cells  (Cai,  Z.,  A.  Brunmark, 
M.P-,.  Jackson,  P.A.  Peterson,  and J.  Sprent,  manuscript 
submitted  for  publication)  are  summarized  in  Fig.  1  b 
(right). 
With regard to Ld.ICAM APC, the data in Figs. 1 and 2 
indicate  that  B7-1  and  ICAM-1  have  distinctly different 
roles  in  negative  selection.  When  coexpressed,  these  two 
costimulatory molecules act synergistically to induce strong 
negative selection to L d plus peptides. However, when ex- 
pressed individually, ICAM-1  protects against negative se- 
lection to L a plus peptides, whereas B7-1  augments nega- 
tive  selection.  These  differences  are  not  apparent  at  the 
level of mature T  cells: thus Ld.B7 and Ld.ICAM APC both 
induce  low  but  significant  proliferative  responses  of LN 
CD8 +  cells to  QL9  (but  not  to  p2Ca)  in  the  absence  of 
added cytokines (Fig. 1 b,  right).  For negative selection, the 
opposing functions of B7-1  and ICAM-1 are not associated 
with differences in CD69  expression (see above,  Fig.  1  b) 
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Figure 3.  Capacity of Ld.ICAM APC to inhibit apoptosis induced by 
L  d APC. Using a fixed total dose of 2 X  10  ~ Drosophila APC/welI, 2C 
CD4+8 + thymocytes (5 ￿  10S/well)  were cultured with QL9 peptide (ll) 
txM), and  various nmnbers of L  d APC  supplemented with  Ld.ICAM, 
1)b.ICAM, or uninduced  APC.  Apoptosis was  measured by TUNEL 
staining at 20 h. It should be noted that QL9 peptide has no detectable ca- 
pacity to bind to D  b molecules. 
or  in  expression  of  Bcl-2  and  related  molecules;  thus, 
Ld.ICAM and La.B7 APC both cause equivalent and mod- 
erately strong upregulation of Bcl-2 on TUNEL-  cells and 
no change in Bcl-X  L or Bax expression (Fig. 1 d. 
The capacity of Ld.ICAM APC  to protect against apop- 
tosis is apparent in mixing experiments with L a APC. Thus, 
apoptosis induced by L a APC plus QL9 is reduced to near- 
background levels by addition of small numbers of La.ICAM 
APC  (Fig. 3).  This effect is less apparent with "bystander" 
Db.ICAM APC  (Fig. 3,  see legend), implying that inhibi- 
tion ofapoptosis is most efficient when L d and ICAM-1 are 
coexpressed on the same APC. (It could be argued that 2C 
DP cells bind preferentailly to Ld.ICAM APC plus peptide, 
thus depriving T  cells from contact with L d APC. This pos- 
sibility is unlikely because conjugate formation in the cul- 
tures  is  tow,  and  is  no  higher  with  Ld.ICAM  APC  than 
with L d APC). 
The  inhibition of apoptosis induced by La.ICAM APC 
presumably reflects recognition of ICAM-1  by the  T  cell 
counterreceptors  for  ICAM-1,  i.e.,  by  LFA-1  (25)  or 
CD43  (26).  In  support  of  this  notion,  the  failure  of 
La.ICAM APC  to  induce  apoptosis to  QL9  can  be  over- 
coine  by  adding  soluble  mAbs  to  ICAM-1,  LFA-1,  or 
CD43  (Fig. 4  a); antibodies to LFA-1 and CD43  are more 
effective as a mixture than when added separately. The res- 
toration of apoptosis induced by soluble anti-ICAM mAb 
also applies when this antibody is cross-linked with anti-rat 
Ig  (Fig.  4  b).  Interestingly,  cross-linking  anti-LFA-1  or 
anti-CD43 mAbs with anti-Rig has the opposite effect and 
reduces apoptosis to low levels (Fig. 4  b). The simplest ex- 
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Figure  4.  Protective role of 
ICAM-1 in negative selection to 
QL9 peptide. 2C CD4+8  + thy- 
mocytes (5 ￿  10S/well) were cul- 
tured with La.ICAM or L  d APC 
(2 ￿  105/well) plus QL9 peptide 
(10 b~M) in the presence of the 
reagents  shown  and  then 
TUNEL stained after 20  h.  (a 
and  b)  Apoptosis induced by 
Ld.ICAM APC plus QL9 in the 
presence of soluble (a) or cross- 
linked (b)  antibodies specific for 
ICAM-1,  LFA-1, or  CD43.  (c 
and d) Apoptosis induced by L  ~ 
APC plus QL9 in the presence of 
cross-linked  antibodies  specific 
for ICAM-1, LFA-1, or CD43 
(c) or in the presence of soluble 
ICAM-1 (S-ICAM) (d). 
planation  for  this  finding  is  that  cross-linking  LFA-1  or 
CD43  molecules  on  T  cells  leads  to  active  signaling  and 
thus  creates  the  same  protective  signal  received  from 
ICAM-1  on La.ICAM APC.  If so, the  apoptosis induced 
by L a APC plus QL9 should be inhibited  (a) by a mixture 
of cross-linked anti-LFA-1 and anti-CD43 mAbs; or (b) by 
soluble ICAM-1. This is indeed the case (Fig. 4, c and d). 
In considering the significance of the different functions 
of ICAM-1 and B7-1 in negative selection, it is of interest 
that ICAM-1 is expressed throughout the thymus, whereas 
B7-1  is expressed  selectively in the  medulla  (27-30).  The 
implication  therefore is  that when  CD4+8 +  cells  undergo 
positive  selection  in the  cortex through contact with  epi- 
thelial  cells,  immature  T  cells  are  exposed to MHC/pep- 
tides  in  conjunction  with  ICAM-1,  but  not  B7-1.  Such 
contact  may  reduce  negative  selection  and  thereby  pro- 
mote positive selection.  When the  maturing T  cells  enter 
the  medulla,  however,  the  combined  expression  of B7-1 
and  ICAM-1  on  marrow-derived  APC  is  conducive  to 
strong negative selection and thus ensures self-tolerance in- 
duction. 
The  capacity  of  ICAM-1  (without  B7-1)  to  protect 
against TCR-mediated  apoptosis of thymocytes has a pre- 
cedent in the finding that LFA-1/ICAM-1 interaction  in- 
hibits  IgM-mediated  apoptosis  of germinal  center  B  cells 
and B  lymphoma cells  (31,  32).  How signaling via LFA-1 
prevents apoptosis is unclear. In the case ofthymocytes, it is 
of interest that combined signaling via CD3 and LFA-1 in- 
hibits glucocorticoid-induced apoptosis (33). Hence, in ad- 
dition to inhibiting negative selection, ICAM-1 expression 
on  cortical  epithelium  may facilitate  positive  selection  by 
inducing steroid resistance  and thus prevent "death by ne- 
glect" from endogenous steroids. 
It should be emphasized that the capacity of  B7-1 or B7-1 
plus  ICAM-1  to  cause  strong  negative  selection  of thy- 
mocytes  in  vitro  does  not  necessarily  indicate  that  these 
molecules play a mandatory role in negative selection un- 
der normal physiological conditions  in vivo. Other mole- 
cules such as Fas  (34), CD40 (8),  CD30 (35), and their re- 
spective  ligands  may play an  equally  (or more)  important 
role under in vivo conditions.  Since the range of costimu- 
latory  molecules  expressed  in  the  thymus  is  considerable, 
many different costimulatory molecules may participate  in 
negative  selection.  If so,  it  is  perhaps  not  surprising  that 
eliminating individual molecules, e.g., CD28 (the counter- 
receptor for B7),  fails  to demonstrably impair negative  se- 
lection  in  vivo  (36).  Because  of this  problem  of "redun- 
dancy," reaching a clear appreciation  of negative selection 
in vivo may be  difficult  and  could  hinge  on  determining 
which particular costimulatory molecules can induce or aug- 
ment negative selection under defined conditions in vitro. 
Testing the function of a variety of different costimulatory 
molecules with the Drosophila  system described here  could 
thus be informative. 
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